ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31734-20mg |
|
143584-75-2 |
S-methyl-KE-298 (M-2)
|
0 | C13H16O3S | |
GC31734-10mg |
|
143584-75-2 |
S-methyl-KE-298 (M-2)
|
0 | C13H16O3S | |
GC31734-5mg |
|
143584-75-2 |
S-methyl-KE-298 (M-2)
|
0 | C13H16O3S | |
GC31734-1mg |
|
143584-75-2 |
S-methyl-KE-298 (M-2)
|
0 | C13H16O3S | |
GC31732-100mg |
|
79338-84-4 |
Tapinarof (WBI 1001)
|
0 | C17H18O2 | |
GC31732-50mg |
|
79338-84-4 |
Tapinarof (WBI 1001)
|
0 | C17H18O2 | |
GC31732-25mg |
|
79338-84-4 |
Tapinarof (WBI 1001)
|
0 | C17H18O2 | |
GC31732-10mg |
|
79338-84-4 |
Tapinarof (WBI 1001)
|
0 | C17H18O2 | |
GC31732-5mg |
|
79338-84-4 |
Tapinarof (WBI 1001)
|
0 | C17H18O2 | |
GC31732-10mM(1mLinDMSO) |
|
79338-84-4 |
Tapinarof (WBI 1001)
|
0 | C17H18O2 | |
GC31731-100mg |
|
2079896-25-4 |
GSK 4027
|
0 | C17H21BrN4O | |
GC31731-50mg |
|
2079896-25-4 |
GSK 4027
|
0 | C17H21BrN4O | |
GC31731-25mg |
|
2079896-25-4 |
GSK 4027
|
0 | C17H21BrN4O | |
GC31731-10mg |
|
2079896-25-4 |
GSK 4027
|
0 | C17H21BrN4O | |
GC31731-5mg |
|
2079896-25-4 |
GSK 4027
|
0 | C17H21BrN4O | |
GC31731-10mM(1mLinDMSO) |
|
2079896-25-4 |
GSK 4027
|
0 | C17H21BrN4O | |
GC31730-500mg |
|
56776-01-3 |
Tulobuterol hydrochloride
|
0 | C12H19Cl2NO | |
GC31730-100mg |
|
56776-01-3 |
Tulobuterol hydrochloride
|
0 | C12H19Cl2NO | |
GC31730-50mg |
|
56776-01-3 |
Tulobuterol hydrochloride
|
0 | C12H19Cl2NO | |
GC31730-10mM(1mLinDMSO) |
|
56776-01-3 |
Tulobuterol hydrochloride
|
0 | C12H19Cl2NO | |